General Information
BounceWatch is an independent company data service, not affiliated with RaNA Therapeutics. To contact RaNA Therapeutics, visit translate.bio.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does RaNA Therapeutics compare?
A PDF of RaNA Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting RaNA Therapeutics soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About RaNA Therapeutics
Funding Rounds & Investors (8)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Post IPO Equity | $125.00M | - |
|
24 Jan 2020 |
| Post IPO Equity | $90.00M | - |
|
17 Sep 2019 |
| Post IPO Equity | $47.45M | - |
|
03 May 2019 |
| Series C | $42.00M | 3 | 01 Dec 2017 | |
| Series C | $51.00M | 6 | 10 Jan 2017 | |
| Series B | $63.81M | 10 | 23 Jul 2015 | |
| Series A | $20.70M | 6 | 18 Jan 2012 | |
| Venture Round | $2.66M | - |
|
30 Nov 2011 |
RaNA Therapeutics Alternatives & Competitors
View All AlternativesAutifony are dedicated to developing new medicines to treat rare genetic CNS disorders
Developing extracellular vesicle (EV) therapies to address rare and serious diseases and disorders
Pioneering therapeutic advancements with innovative solutions for rare genetic hemoglobin disorders.
FAQ About RaNA Therapeutics
Source: BounceWatch company record for RaNA Therapeutics, https://bouncewatch.com/company/translate-bio, updated 12 April 2026. When citing, please name BounceWatch and link this page.